Details for Patent: 9,763,577
Which drugs does patent 9,763,577 protect, and when does it expire?
Patent 9,763,577 protects LUMISIGHT and is included in one NDA.
This patent has fourteen patent family members in seven countries.
Summary for Patent: 9,763,577
| Title: | Imaging agent for detection of diseased cells |
| Abstract: | The present invention provides compositions and methods for imaging, for example, tumor resections. |
| Inventor(s): | W. David Lee, Moungi G. Bawendi, Jorge Ferrer |
| Assignee: | Lumicell Inc |
| Application Number: | US14/211,014 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,763,577
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lumicell | LUMISIGHT | pegulicianine acetate | POWDER;INTRAVENOUS | 214511-001 | Apr 17, 2024 | RX | Yes | Yes | 9,763,577 | ⤷ Start Trial | Y | Y | A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,763,577
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014236561 | ⤷ Start Trial | |||
| Canada | 2906056 | ⤷ Start Trial | |||
| China | 105473051 | ⤷ Start Trial | |||
| European Patent Office | 2967280 | ⤷ Start Trial | |||
| Japan | 2016520339 | ⤷ Start Trial | |||
| Japan | 2019111351 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
